FFG
Frisch Financial Group’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.42M | Buy |
7,673
+32
| +0.4% | +$5.94K | 0.35% | 45 |
|
2025
Q1 | $1.6M | Sell |
7,641
-282
| -4% | -$59.1K | 0.45% | 36 |
|
2024
Q4 | $1.41M | Buy |
7,923
+193
| +2% | +$34.3K | 0.43% | 38 |
|
2024
Q3 | $1.53M | Buy |
7,730
+810
| +12% | +$160K | 0.46% | 35 |
|
2024
Q2 | $1.19M | Buy |
6,920
+53
| +0.8% | +$9.09K | 0.36% | 40 |
|
2024
Q1 | $1.25M | Sell |
6,867
-108
| -2% | -$19.7K | 0.42% | 33 |
|
2023
Q4 | $1.08M | Buy |
6,975
+36
| +0.5% | +$5.58K | 0.41% | 36 |
|
2023
Q3 | $1.03M | Sell |
6,939
-140
| -2% | -$20.9K | 0.42% | 39 |
|
2023
Q2 | $954K | Sell |
7,079
-305
| -4% | -$41.1K | 0.46% | 41 |
|
2023
Q1 | $1.18M | Buy |
7,384
+65
| +0.9% | +$10.4K | 0.46% | 42 |
|
2022
Q4 | $1.18M | Buy |
7,319
+1
| +0% | +$162 | 0.44% | 44 |
|
2022
Q3 | $982K | Buy |
7,318
+234
| +3% | +$31.4K | 0.42% | 41 |
|
2022
Q2 | $1.09M | Buy |
7,084
+60
| +0.9% | +$9.19K | 0.42% | 41 |
|
2022
Q1 | $1.14M | Sell |
7,024
-1,226
| -15% | -$199K | 0.37% | 47 |
|
2021
Q4 | $1.11M | Sell |
8,250
-184
| -2% | -$24.7K | 0.35% | 49 |
|
2021
Q3 | $910K | Buy |
8,434
+61
| +0.7% | +$6.58K | 0.3% | 49 |
|
2021
Q2 | $943K | Buy |
8,373
+165
| +2% | +$18.6K | 0.3% | 52 |
|
2021
Q1 | $888K | Buy |
8,208
+145
| +2% | +$15.7K | 0.3% | 51 |
|
2020
Q4 | $864K | Buy |
8,063
+322
| +4% | +$34.5K | 0.32% | 40 |
|
2020
Q3 | $678K | Buy |
7,741
+91
| +1% | +$7.97K | 0.3% | 44 |
|
2020
Q2 | $751K | Sell |
7,650
-8,124
| -52% | -$798K | 0.35% | 38 |
|
2020
Q1 | $1.2M | Buy |
15,774
+5,919
| +60% | +$451K | 0.7% | 30 |
|
2019
Q4 | $873K | Buy |
9,855
+6,013
| +157% | +$533K | 0.41% | 42 |
|
2019
Q3 | $291K | Buy |
+3,842
| New | +$291K | 0.18% | 76 |
|
2019
Q1 | – | Sell |
-2,409
| Closed | -$222K | – | 105 |
|
2018
Q4 | $222K | Buy |
+2,409
| New | +$222K | 0.16% | 87 |
|